The intelligence layer for global biotech sourcing.
Biotech Buyer connects manufacturers, pharmaceutical suppliers, laboratories, and institutional buyers through a curated network built on data, diligence, and discretion.
Sourcing as an
institutional discipline.
Our network is engineered for participants who require precision, discretion, and scale. Each capability is delivered by senior practitioners and supported by a verified data layer.
Manufacturer sourcing
Identify pre-vetted biotech and pharmaceutical manufacturers across cell therapy, biologics, and small-molecule production with verified capacity and regulatory standing.
- FDA, EMA, PMDA credentialing
- GMP capacity intelligence
- Quality, scale, and IP diligence
Buyer acquisition
Curated introductions to institutional buyers — strategic acquirers, healthcare investors, sovereign funds, and global procurement teams operating with mandate and capital.
- Mandate-matched introductions
- Confidential outreach protocols
- Stage-aligned investor mapping
Market intelligence
Continuous, structured intelligence on supply, demand, and pricing across regulated life sciences markets — informed by primary research and verified counterparties.
- Supply and demand telemetry
- Regulatory horizon scanning
- Comparable transaction data
Transaction advisory
Senior advisory through diligence, structuring, and close — with discretion appropriate to cross-border life sciences transactions and institutional standards.
- Diligence orchestration
- Structuring and negotiation support
- Cross-border legal coordination
Capital and intent,
introduced with discretion.
Every counterparty is verified on standing, mandate, and capital before introduction. We do not list. We curate, qualify, and place — engagement by engagement.
- EMEAStrategic acquirer· Cell & gene therapy mandateEngaged
- APACSovereign fund· Late-stage biologicsReviewing
- AmericasSpecialty growth fund· Oncology platformsIntroduced
- EMEAHealth-system procurement· Cold-chain capacitySourcing
A network with
planetary coverage.
Senior practitioners across four regions operate under a single mandate: surface and qualify the most relevant counterparties for each engagement, anywhere in the world.
Trust is engineered,
not implied.
"Biotech Buyer surfaced counterparties our internal team had not seen in eighteen months of mandate development. The diligence was institution-grade."
"We treat their introductions the way we treat introductions from the most senior banks. Considered, qualified, and worth the room."
"Discreet, precise, and globally fluent. They understand that our reputation travels with every introduction."
Every entrant is manually credentialed against regulatory standing, capital, and mandate.
Engagements operate under NDA, with controlled disclosure and end-to-end encrypted exchange.
Engagements are led by partners with operating histories at global pharma, regulators, and capital allocators.
Begin a confidential conversation.
Engagements are accepted by referral and selective inbound. Share your mandate and a senior partner will respond within one business day.